Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by blocking renal glucose reabsorption, promoting urinary glucose excretion. It is used as an oral antidiabetic agent in Type 2 Diabetes Mellitus, often as part of combination therapy.
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by blocking renal glucose reabsorption, promoting urinary glucose excretion. It is used as an oral antidiabetic agent in Type 2 Diabetes Mellitus, often as part of combination therapy.
| Parameter | Specification |
|---|---|
| Chemical Name | Canagliflozin |
| CAS Number | 842133-18-0 |
| Molecular Formula | C₂₄H₂₅FO₅S |
| Molecular Weight | 444.52 g/mol |
| Purity | ≥ 99.0% |
| Appearance | White to off-white crystalline powder |
| Solubility | Practically insoluble in water |
| Grade | Pharmaceutical Grade |
| Storage | Store below 30°C, protect from light and moisture |
| Batch Size | 10 grams to 250 kg lots |
| Available Documentation | CoA, CoO, DMF, MSDS |
Patent Notice: Products under patents are offered subject to the patent laws of the importing countries. The buyer is solely responsible for compliance with patent rights in any specific country.